Andrew Bendheim
Member, Board of Directors

As a Board Member, Andrew brings Aster Impact a wealth of knowledge from almost 30 years of experience in marketing, finance, and business operations. His expertise includes international and direct marketing, budgeting and financial modeling, intellectual property management, and project and process management.

Andrew is the current CEO of Agency for Medical Innovations, Inc. (AMI). Before joining AMI, he was the Chief Financial Officer and Chief Operating Officer at MEDCHANNEL, LLC. He also served as COO for EKMS/UTEK Consulting, a business consulting firm specializing in leveraging intellectual property, including medical devices. He has also worked for Hasbro, developing new business channels, and spent most of his career as head of the Trade Development Department of the Massachusetts Port Authority. At Massport, he helped medical device companies build overseas partnerships and distributor networks. Andrew received a BA from Trinity College and an MBA from Columbia Business School.